-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – Pramipexole in Parkinson’s Disease
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Pramipexole in Parkinson's Disease report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Pramipexole in Parkinson's Disease Drug Details: Pramipexole is under development for the...
-
Product Insights
Pulmonary Embolism – Drugs In Development, 2023
Global Markets Direct’s, ‘Pulmonary Embolism - Drugs In Development, 2023’, provides an overview of the Pulmonary Embolism pipeline landscape. The report provides comprehensive information on the therapeutics under development for Pulmonary Embolism, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an...
-
Product Insights
Acute Opioid Overdosage – Drugs In Development, 2023
Global Markets Direct’s, ‘Acute Opioid Overdosage - Drugs In Development, 2023’, provides an overview of the Acute Opioid Overdosage pipeline landscape. The report provides comprehensive information on the therapeutics under development for Acute Opioid Overdosage, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the...
-
Product Insights
Deep Vein Thrombosis (DVT) – Drugs In Development, 2023
Global Markets Direct’s, ‘Deep Vein Thrombosis (DVT) - Drugs In Development, 2023’, provides an overview of the Deep Vein Thrombosis (DVT) pipeline landscape. The report provides comprehensive information on the therapeutics under development for Deep Vein Thrombosis (DVT), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press...
-
Product Insights
Venous (Vein) Thrombosis – Drugs In Development, 2023
Global Markets Direct’s, ‘Venous (Vein) Thrombosis - Drugs In Development, 2023’, provides an overview of the Venous (Vein) Thrombosis pipeline landscape. The report provides comprehensive information on the therapeutics under development for Venous (Vein) Thrombosis, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the...
-
Product Insights
Lennox-Gastaut Syndrome – Drugs In Development, 2023
Global Markets Direct’s, ‘Lennox-Gastaut Syndrome - Drugs In Development, 2023’, provides an overview of the Lennox-Gastaut Syndrome pipeline landscape. The report provides comprehensive information on the therapeutics under development for Lennox-Gastaut Syndrome, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an...
-
Product Insights
Thromboembolism – Drugs In Development, 2023
Global Markets Direct’s, ‘Thromboembolism - Drugs In Development, 2023’, provides an overview of the Thromboembolism pipeline landscape. The report provides comprehensive information on the therapeutics under development for Thromboembolism, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key...
-
Product Insights
Venous Thromboembolism – Drugs In Development, 2023
Global Markets Direct’s, ‘Venous Thromboembolism - Drugs In Development, 2023’, provides an overview of the Venous Thromboembolism pipeline landscape. The report provides comprehensive information on the therapeutics under development for Venous Thromboembolism, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an...
-
Product Insights
Childhood Epilepsy – Drugs In Development, 2023
Global Markets Direct’s, ‘Childhood Epilepsy - Drugs In Development, 2023’, provides an overview of the Childhood Epilepsy pipeline landscape. The report provides comprehensive information on the therapeutics under development for Childhood Epilepsy, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an...
-
Product Insights
Thrombosis – Drugs In Development, 2023
Global Markets Direct’s, ‘Thrombosis - Drugs In Development, 2023’, provides an overview of the Thrombosis pipeline landscape. The report provides comprehensive information on the therapeutics under development for Thrombosis, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key...